InnoCan Pharma (TSE:INNO) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Innocan Pharma has announced promising results from a safety assessment of its LPT-CBD injectable on minipigs, showing excellent tolerance and no adverse effects. This study supports the feasibility of LPT-CBD’s safety evaluations, paving the way for future regulatory milestones in chronic pain treatment.
For further insights into TSE:INNO stock, check out TipRanks’ Stock Analysis page.
